CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+19.55%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$19.7M
AUM Growth
+$19.7M
(+12%)
Cap. Flow
+$205K
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
99.71%
Holding
12
New
1
Increased
5
Reduced
1
Closed
–
Top Buys
| 1 |
Lexeo Therapeutics
LXEO
|
$121K |
| 2 |
Kyverna Therapeutics
KYTX
|
$53.5K |
| 3 |
Context Therapeutics
CNTX
|
$36.9K |
| 4 |
MindMed
MNMD
|
$9.5K |
| 5 |
SPDR S&P 500 ETF Trust
SPY
|
$7.07K |
Top Sells
| 1 |
ABVX
Abivax
ABVX
|
$25.2K |
Sector Composition
| 1 | Healthcare | 92.73% |
| 2 | Financials | 2.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Xeris Biopharma Holdings
XERS
$1.26B
| $11.5M | 58.31% |
5,113,348
| – | – |
|
2
Rezolute
RZLT
$619M
| $5.67M | 28.74% |
1,318,967
| – | – |
|
|
3
SPDR S&P 500 ETF Trust
SPY
$658B
| $1.02M | 5.15% |
1,869
+13
| +0.7% | +$7.07K |
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $417K | 2.11% |
1,025
+6
| +0.6% | +$2.44K |
|
|
5
Lexeo Therapeutics
LXEO
$259M
| $286K | 1.45% |
17,851
+7,532
| +73% | +$121K |
|
|
6
MindMed
MNMD
$676M
| $219K | 1.11% |
30,383
+1,318
| +5% | +$9.5K |
|
|
ABVX
7
Abivax
ABVX
$6.12B
| $184K | 0.93% |
13,900
-1,908
| -12% | -$25.2K |
|
|
8
Kyverna Therapeutics
KYTX
$160M
| $172K | 0.87% |
22,981
+7,135
| +45% | +$53.5K |
|
|
MTEM
9
DELISTED
Molecular Templates, Inc.
MTEM
| $157K | 0.8% |
136,866
| – | – |
|
10
Compass Therapeutics
CMPX
$483M
| $43.5K | 0.22% |
43,465
| – | – |
|
|
11
Context Therapeutics
CNTX
$75.4M
| $36.9K | 0.19% |
+18,403
| New | +$36.9K |
|
12
Adicet Bio
ACET
$59.9M
| $21.2K | 0.11% |
17,488
| – | – |
|